Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
FHTX
#2701
Foghorn Therapeutics Inc. Common Stock
5.680
0
+0.89%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+0.89%
Monthly Change
-3.97%
6 month change
+39.22%
Cambio anual
+39.22%
Cierres anteriores
5.630
0
Open
5.680
0
Bid
Ask
Low
5.680
0
High
5.680
0
Volumen
33
Markets
Acciones
Atención Sanitaria
FHTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
Foghorn Therapeutics nomina Ryan Maynard come direttore finanziario
Foghorn Therapeutics names Ryan Maynard as chief financial officer
Jefferies initiates Foghorn Therapeutics stock with buy rating
I migliori titoli sanitari per quest’anno secondo BTIG
Top Healthcare Stocks for This Year According to BTIG
Azioni Foghorn Therapeutics riconfermate come Acquisto da BTIG, nominate top pick per il 1H26
Foghorn Therapeutics stock reaffirmed as Buy by BTIG, named top pick for 1H26
Stifel conferma il rating Buy sulle azioni di Foghorn Therapeutics con target di $12
Stifel reiterates Buy rating on Foghorn Therapeutics stock at $12 target
3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment
BTIG avvia la copertura su Foghorn Therapeutics con rating Buy grazie alla pipeline oncologica
BTIG initiates Foghorn Therapeutics stock with Buy rating on cancer pipeline